title: Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?
authors.forename: S
authors.initials: S
authors.lastname: Bahri
authors.forename: J-H
authors.initials: JH
authors.lastname: Chen
authors.forename: H J
authors.initials: HJ
authors.lastname: Yu
authors.forename: A
authors.initials: A
authors.lastname: Kuzucan
authors.forename: O
authors.initials: O
authors.lastname: Nalcioglu
authors.forename: M-Y
authors.initials: MY
authors.lastname: Su
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla; D001943:Breast Neoplasms / Q000098:blood supply / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000175:diagnosis; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000098:blood supply / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000175:diagnosis; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D011795:Surveys and Questionnaires; D013689:Telephone